Navigation Links
OPX Biotechnologies Selected as Innovation Pioneer at IHS CERAWeek
Date:3/4/2013

Boulder, Colo. (PRWEB) March 04, 2013

Bio-based chemicals and fuels producer OPX Biotechnologies Inc. (OPXBIO) is being recognized as an Energy Innovation Pioneer at this week’s annual IHS CERAWeek conference in Houston – an honor that further signals the increasing role that bio-based producers can play in the global energy and chemical industries.

The annual Energy Innovation Pioneers program recognizes companies for their “potential to transform the energy future,” a goal that perfectly mirrors OPXBIO’s objective to transform the business of chemistry, according to president and CEO Charles R. (Chas) Eggert. With volatile and escalating petroleum prices, increasing regulatory constraints and growing consumer demands for more-sustainable products, OPXBIO can help existing petroleum-based manufacturers adopt new bio-based technology to successfully meet these challenges.

“Many conference attendees represent well-established, major oil & gas players, but the fact that a bio-based start-up like OPXBIO is also invited shows the industry recognizes the opportunity for new economic bio-processes to make chemicals and fuels,” Eggert said. “Today’s petroleum-based manufacturers are constantly striving for more-efficient process technology. Our process improvements use the rapid advancements in biotechnology and are accomplished using living cells engineered to perform as efficient, microscopic factories."

The Energy Innovation Pioneers program is held annually in conjunction with IHS CERAWeek, which is being held March 4-8 at the Hilton Americas-Houston. This year’s Energy Innovation Pi-oneers were selected based on creativity, plan feasibility, technology scalability and leadership team. The program recognized OPXBIO for developing bio-based processes that can use a variety of feedstocks to create renewable chemicals and fuels used in everything from consumer products to jet fuel.

OPXBIO, for example, is partnering with The Dow Chemical Co. to bring BioAcrylic – a direct and more-sustainable replacement for petro-based acrylic acid – into the $10-billion acrylic acid mar-ket for use in consumer products such as diapers, detergents, paints and adhesives. OPXBIO has also demonstrated lab-scale production of its second product – fatty acid from syngas for chemical and fuel applications – in a project that is supported by an award from the U.S. Department of Energy.

Eggert will present an overview of OPXBIO during an Energy Innovation Pioneers breakfast session on Tuesday, March 5 at 7:30 a.m., and again that same day at the conference’s Innovation Pioneer Showcase at 3:30 p.m.

About OPXBIO
OPX Biotechnologies (OPXBIO) is a leader in sustainably transforming the business of chemistry. As the "Good Chemistry" company, OPXBIO provides more sustainable value to customers by applying its proprietary EDGE ™ (Efficiency Directed Genome Engineering) technology to produce economic, bio-based chemicals that directly replace existing petroleum-based products. OPXBIO's EDGE is versatile and enables faster, more efficient development of bioprocesses using a variety of feedstocks. Founded in 2007, OPXBIO is financed by leading venture capital investors, and employs 65 people in Boulder, Colo.

For more information, visit http://www.opxbio.com.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10492128.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Leading Scientists to Debate Views on Rejuvenation Biotechnologies
2. Lifeline Biotechnologies Receives Patent for Methods to Collect and Analyze Breast Thermal Data to Determine Suspect Conditions
3. Medical Marijuana, Inc. Portfolio Company CanChew BioTechnologies Inc. Updates and Expands Free Product Trial
4. Adaptive Biotechnologies launches clonoSEQ, a more sensitive, accurate assay to detect minimal residual disease (MRD) in blood-based cancers.
5. inVentiv Health Selected to Provide Sales Operations Support for Santarus
6. Webcor Builders Selected as the General Contractor for First Phase of LA BioMeds New Campus Master Plan
7. KGI Selected to Administer PSM Affiliation Process
8. Conflict of Interest Management System Selected by Via Christi Health
9. invivodata President Selected as Finalist for Ernst & Young Entrepreneur of the Year Award
10. Reno Efficient Sustainable Practices Selected to Provide Water and Energy Conservation Services To the County of San Diego
11. Companies Selected to Present at AdvaMed 2012 Announced
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... data bioInformatics portal. In response to client demand KbioBox developed a sophisticated “3 ... biodesign program. Both are accessible from KBioBox’s new website, https://www.kbiobox.com/ ...
(Date:12/8/2016)... ... December 08, 2016 , ... This CAST literature review and ... crops. The authors focus on the economic effects in countries that are major global ... biotech crops and the resultant risk of low level presence (LLP) puts large volumes ...
(Date:12/8/2016)...  HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), a clinical ... to commercialize innovative therapeutics for patients with cancer, ... approved for trading on the OTCQX U.S. market. ... effective today, under the ticker symbol "HPPI." ... must meet high financial standards, follow best practice ...
(Date:12/8/2016)... 2016  Partnering to fuel Philadelphia,s ... of Southeastern Pennsylvania (" Ben ... of Independence Blue Cross; and Safeguard Scientifics ("Safeguard") (NYSE: ... a $6 million funding initiative over a four year ... Responding to a burgeoning economic vitality in digital health, ...
Breaking Biology Technology:
(Date:12/7/2016)... BioCatch , the global leader in behavioral biometrics, reported a ... over 40 granted and pending patents. ... , The Company,s IP portfolio expansion ... Device, and Method Estimating Force Applied to a Touch Surface, " ... components needed to estimate the force and pressure applied to touch surfaces ...
(Date:12/6/2016)... 6, 2016  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... offering of €500.0 million principal amount of its 1.414% senior ... its 2.425% senior unsecured notes due 2026. ... December 13, 2016, subject to the satisfaction of customary closing conditions.  ... The Company intends to use the ...
(Date:12/5/2016)... 5, 2016  The Office of Justice Programs, ... CT Scans Enhance or Replace Medico Legal Autopsies?" ... supporting or replacing forensic autopsies with postmortem X-ray ... In response to recommendations made by The ... CT scans as a potential component of medicolegal ...
Breaking Biology News(10 mins):